By Helgi Analytics - April 2, 2020
Alliance Healthcare Czech Republic's total assets reached CZK 4,907 mil at the end of 2017, up 6.56% compared to the previous ye...
| Profit Statement | 2015 | 2016 | 2017 | |
| Sales | CZK mil | ... | 16,447 | 17,300 |
| Gross Profit | CZK mil | ... | 508 | 565 |
| EBITDA | CZK mil | ... | 293 | 342 |
| EBIT | CZK mil | ... | 264 | 310 |
| Financing Cost | CZK mil | ... | 5.16 | 2.25 |
| Pre-Tax Profit | CZK mil | ... | 258 | 308 |
| Net Profit | CZK mil | ... | 208 | 251 |
| Balance Sheet | 2015 | 2016 | 2017 | |
| Total Assets | CZK mil | ... | 4,605 | 4,907 |
| Non-Current Assets | CZK mil | ... | 368 | 393 |
| Current Assets | CZK mil | ... | 4,222 | 4,489 |
| Working Capital | CZK mil | ... | 1,665 | 1,579 |
| Shareholders' Equity | CZK mil | ... | 948 | 971 |
| Liabilities | CZK mil | ... | 3,657 | 3,936 |
| Total Debt | CZK mil | ... | 956 | 1,056 |
| Net Debt | CZK mil | ... | 849 | 767 |
| Ratios | 2015 | 2016 | 2017 | |
| ROE | % | ... | 21.9 | 26.2 |
| ROCE | % | ... | ... | 12.5 |
| Gross Margin | % | ... | 3.09 | 3.27 |
| EBITDA Margin | % | ... | 1.78 | 1.98 |
| EBIT Margin | % | ... | 1.60 | 1.79 |
| Net Margin | % | ... | 1.26 | 1.45 |
| Net Debt/EBITDA | ... | 2.90 | 2.25 | |
| Net Debt/Equity | % | ... | 89.5 | 79.0 |
| Cost of Financing | % | ... | ... | 0.224 |
| Cash Flow | 2015 | 2016 | 2017 | |
| Total Cash From Operations | CZK mil | ... | 251 | 366 |
| Total Cash From Investing | CZK mil | ... | -19.9 | -57.0 |
| Total Cash From Financing | CZK mil | ... | -166 | -128 |
| Net Change In Cash | CZK mil | ... | 64.9 | 181 |
| Cash Conversion Cycle | days | ... | 36.1 | 32.4 |
| Cash Earnings | CZK mil | ... | 237 | 283 |
| Free Cash Flow | CZK mil | ... | 231 | 309 |
Get all company financials in excel:
| summary | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| income statement | |||||||||||||
| Sales | CZK mil | 13,416 | 14,082 | 13,794 | 20,974 | ... | |||||||
| Gross Profit | CZK mil | 425 | 460 | 486 | 643 | ... | |||||||
| EBIT | CZK mil | 220 | 243 | 265 | 330 | ... | |||||||
| Net Profit | CZK mil | 157 | 178 | 202 | 239 | ... | |||||||
| ROE | % | 26.1 | 28.0 | 30.1 | 33.4 | ... | |||||||
| EBIT Margin | % | 1.64 | 1.73 | 1.92 | 1.57 | ... | |||||||
| Net Margin | % | 1.17 | 1.26 | 1.47 | 1.14 | ... | |||||||
| Employees | 401 | 382 | 376 | 365 | ... | ||||||||
| balance sheet | |||||||||||||
| Total Assets | CZK mil | 3,975 | 4,032 | 4,030 | 3,992 | ... | |||||||
| Non-Current Assets | CZK mil | 411 | 386 | 382 | 377 | ... | |||||||
| Current Assets | CZK mil | 3,562 | 3,643 | 3,646 | 3,609 | ... | |||||||
| Shareholders' Equity | CZK mil | 621 | 650 | 693 | 740 | ... | |||||||
| Liabilities | CZK mil | 3,354 | 3,382 | 3,337 | 3,253 | ... | |||||||
| Non-Current Liabilities | CZK mil | 759 | 759 | 756 | 756 | ... | |||||||
| Current Liabilities | CZK mil | 2,102 | 2,125 | 2,057 | 2,112 | ... | |||||||
| Net Debt/EBITDA | 4.85 | 4.46 | 4.23 | 2.93 | ... | ||||||||
| Net Debt/Equity | % | 198 | 188 | 181 | 147 | ... | |||||||
| Cost of Financing | % | ... | 1.96 | 1.92 | 2.09 | 2.94 | ... | ... | |||||
| cash flow | |||||||||||||
| Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| income statement | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| income statement | |||||||||||||
| Sales | CZK mil | 13,416 | 14,082 | 13,794 | 20,974 | ... | |||||||
| Cost of Goods & Services | CZK mil | 12,991 | 13,622 | 13,308 | 20,330 | ... | |||||||
| Gross Profit | CZK mil | 425 | 460 | 486 | 643 | ... | |||||||
| Staff Cost | CZK mil | 160 | 163 | 167 | 255 | ... | |||||||
| Other Cost | CZK mil | 11.4 | 21.9 | 21.9 | 17.1 | ... | |||||||
| EBITDA | CZK mil | 254 | 275 | 297 | 372 | ... | |||||||
| Depreciation | CZK mil | 33.9 | 31.9 | 31.9 | 41.6 | ... | |||||||
| EBIT | CZK mil | 220 | 243 | 265 | 330 | ... | |||||||
| Financing Cost | CZK mil | 24.7 | 23.8 | 26.2 | 35.4 | ... | |||||||
| Extraordinary Cost | CZK mil | 0 | 0 | 0 | 0 | ... | |||||||
| Pre-Tax Profit | CZK mil | 195 | 219 | 238 | 295 | ... | |||||||
| Tax | CZK mil | 38.8 | 41.3 | 36.0 | 55.1 | ... | |||||||
| Minorities | CZK mil | 0 | 0 | 0 | 0 | ... | |||||||
| Net Profit | CZK mil | 157 | 178 | 202 | 239 | ... | |||||||
| growth rates | |||||||||||||
| Total Revenue Growth | % | ... | 2.08 | 4.97 | -2.05 | 52.0 | ... | ... | |||||
| Operating Cost Growth | % | ... | -9.54 | 8.39 | 2.05 | 43.7 | ... | ... | |||||
| EBITDA Growth | % | ... | 0.857 | 8.21 | 7.88 | 25.3 | ... | ... | |||||
| EBIT Growth | % | ... | 1.33 | 10.4 | 8.92 | 24.7 | ... | ... | |||||
| Pre-Tax Profit Growth | % | ... | 3.69 | 12.2 | 8.78 | 23.6 | ... | ... | |||||
| Net Profit Growth | % | ... | 2.35 | 13.6 | 13.8 | 18.3 | ... | ... | |||||
| ratios | |||||||||||||
| ROE | % | 26.1 | 28.0 | 30.1 | 33.4 | ... | |||||||
| ROCE | % | ... | 8.41 | 8.88 | 9.80 | 12.9 | ... | ... | |||||
| Gross Margin | % | 3.17 | 3.27 | 3.52 | 3.07 | ... | |||||||
| EBITDA Margin | % | 1.89 | 1.95 | 2.15 | 1.77 | ... | |||||||
| EBIT Margin | % | 1.64 | 1.73 | 1.92 | 1.57 | ... | |||||||
| Net Margin | % | 1.17 | 1.26 | 1.47 | 1.14 | ... | |||||||
| Cost of Financing | % | ... | 1.96 | 1.92 | 2.09 | 2.94 | ... | ... | |||||
| Net Debt/EBITDA | 4.85 | 4.46 | 4.23 | 2.93 | ... |
| balance sheet | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| balance sheet | |||||||||||||
| Non-Current Assets | CZK mil | 411 | 386 | 382 | 377 | ... | |||||||
| Property, Plant & Equipment | CZK mil | 398 | 375 | 375 | 367 | ... | |||||||
| Intangible Assets | CZK mil | 11.4 | 9.91 | 5.32 | 9.06 | ... | |||||||
| Current Assets | CZK mil | 3,562 | 3,643 | 3,646 | 3,609 | ... | |||||||
| Inventories | CZK mil | 869 | 825 | 865 | 902 | ... | |||||||
| Receivables | CZK mil | 2,592 | 2,639 | 2,616 | 2,492 | ... | |||||||
| Cash & Cash Equivalents | CZK mil | 12.8 | 11.3 | 16.9 | 42.6 | ... | |||||||
| Total Assets | CZK mil | 3,975 | 4,032 | 4,030 | 3,992 | ... | |||||||
| Shareholders' Equity | CZK mil | 621 | 650 | 693 | 740 | ... | |||||||
| Of Which Minority Interest | CZK mil | 0 | 0 | 0 | 0 | ... | |||||||
| Liabilities | CZK mil | 3,354 | 3,382 | 3,337 | 3,253 | ... | |||||||
| Non-Current Liabilities | CZK mil | 759 | 759 | 756 | 756 | ... | |||||||
| Long-Term Debt | CZK mil | 756 | 756 | 756 | 756 | ... | |||||||
| Deferred Tax Liabilities | CZK mil | 0 | 0 | 0.341 | 0 | ... | |||||||
| Current Liabilities | CZK mil | 2,102 | 2,125 | 2,057 | 2,112 | ... | |||||||
| Short-Term Debt | CZK mil | 488 | 481 | 515 | 376 | ... | |||||||
| Trade Payables | CZK mil | 2,030 | 1,689 | 1,896 | 2,013 | ... | |||||||
| Provisions | CZK mil | 12.5 | 21.7 | 14.2 | 5.76 | ... | |||||||
| Equity And Liabilities | CZK mil | 3,975 | 4,032 | 4,030 | 3,992 | ... | |||||||
| growth rates | |||||||||||||
| Total Asset Growth | % | ... | 11.3 | 1.42 | -0.054 | -0.930 | ... | ... | |||||
| Shareholders' Equity Growth | % | ... | 7.04 | 4.69 | 6.52 | 6.82 | ... | ... | |||||
| Net Debt Growth | % | ... | -1.40 | -0.485 | 2.31 | -13.1 | ... | ... | |||||
| Total Debt Growth | % | ... | -2.48 | -0.597 | 2.74 | -10.9 | ... | ... | |||||
| ratios | |||||||||||||
| Total Debt | CZK mil | 1,244 | 1,237 | 1,271 | 1,132 | ... | |||||||
| Net Debt | CZK mil | 1,231 | 1,225 | 1,254 | 1,089 | ... | |||||||
| Working Capital | CZK mil | 1,431 | 1,775 | 1,585 | 1,381 | ... | |||||||
| Capital Employed | CZK mil | 1,842 | 2,162 | 1,967 | 1,758 | ... | |||||||
| Net Debt/Equity | % | 198 | 188 | 181 | 147 | ... | |||||||
| Cost of Financing | % | ... | 1.96 | 1.92 | 2.09 | 2.94 | ... | ... |
| cash flow | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| cash flow | |||||||||||||
| Net Profit | CZK mil | 157 | 178 | 202 | 239 | ... | |||||||
| Depreciation | CZK mil | 33.9 | 31.9 | 31.9 | 41.6 | ... | |||||||
| Non-Cash Items | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Change in Working Capital | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Capital Expenditures | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Other Investments | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Issuance Of Shares | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Issuance Of Debt | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| ratios | |||||||||||||
| Days Sales Outstanding | days | 70.5 | 68.4 | 69.2 | 43.4 | ... | |||||||
| Days Sales Of Inventory | days | 24.4 | 22.1 | 23.7 | 16.2 | ... | |||||||
| Days Payable Outstanding | days | 57.0 | 45.3 | 52.0 | 36.1 | ... | |||||||
| Cash Conversion Cycle | days | 37.9 | 45.3 | 41.0 | 23.4 | ... | |||||||
| Cash Earnings | CZK mil | 190 | 210 | 234 | 281 | ... | |||||||
| Free Cash Flow | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| other data | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| other data | |||||||||||||
| ROA | % | 4.15 | 4.44 | 5.02 | 5.97 | ... | |||||||
| Gross Margin | % | 3.17 | 3.27 | 3.52 | 3.07 | ... | |||||||
| Employees | 401 | 382 | 376 | 365 | ... | ||||||||
| Cost Per Employee | USD per month | 1,874 | 1,823 | 1,894 | 2,720 | ... | |||||||
| Cost Per Employee (Local Currency) | CZK per month | 33,148 | 35,649 | 37,059 | 58,138 | ... | |||||||
| Staff Cost (As % Of Total Cost) | % | 1.21 | 1.18 | 1.24 | 1.23 | ... | |||||||
| Effective Tax Rate | % | 19.9 | 18.8 | 15.1 | 18.7 | ... | |||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
Alliance Healthcare s.r.o. is Czech Republic-based subsidiary of the wholesale division of Europe's provider of health services - Alliance Boots. Key activities are the distribution of pharmaceutical products to independent pharmacies and hospitals. Alliance Healthcare is a leading international provider of pharmaceutical wholesale, offering services to independent pharmacists and pharmaceutical manufacturers across Europe and beyond. It also supports a large network of independent pharmacies across Europe. Alliance Healthcare is a member of Walgreens Boots Alliance.
Alliance Healthcare Czech Republic has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 4.46% a year during that time to total of CZK 342 mil in 2017, or 1.98% of sales. That’s compared to 1.92% average margin seen in last five years.
The company netted CZK 251 mil in 2017 implying ROE of 26.2% and ROCE of 12.5%. Again, the average figures were 27.9% and 11.7%, respectively when looking at the previous 5 years.
Alliance Healthcare Czech Republic’s net debt amounted to CZK 767 mil at the end of 2017, or 79.0% of equity. When compared to EBITDA, net debt was 2.25x, down when compared to average of 3.07x seen in the last 5 years.
Helgi Analytics 
